Bitcoin mining companies pivoting to AI infrastructure saw a strong rally, but recent insider stock sales and shareholder trims during this surge have raised questions about liquidity and alignment with investors. Key players like TeraWulf announced major AI leases while insiders sold shares, prompting scrutiny on who benefits from the AI boom. Similar patterns appeared at Cipher, Riot Platforms, and Core Scientific, where executives sold stock under prearranged plans. Meanwhile, IREN faced criticism over large executive stock grants amid governance concerns. This signals a shift from excitement over AI infrastructure scarcity to focus on governance, capital discipline, and insider incentives as the sector cools.
Bitcoin balances on major exchanges increased notably, with a net inflow of over 1,100 BTC in 24 hours and more than 6,400 BTC over a month, reflecting growing sell-side readiness and trading activity. Binance saw a sharp rise in U.S. trading hours v...
Swedish Orphan Biovitrum (Sobi) and Innate Pharma have formed a strategic partnership to initiate the TELLOMAK-3 Phase 3 trial for lacutamab, targeting cutaneous T-cell lymphoma (CTCL), including Sézary syndrome. This trial is a key step toward accel...
ImmuPharma has appointed Kymos Group as the bioanalytical partner for its diabetes drug candidate Kapiglucagon, completing its outsourced development team. Kymos will develop and validate methods to measure the drug in biological samples and analyze ...
Bitcoin's 30-day demand has turned positive near 25,000 BTC after a sharp drop, signaling returning capital mainly driven by derivatives. However, for a sustainable recovery, stronger spot market participation is needed to absorb overhead supply and ...
ASM International N.V. has launched a share buyback program worth up to €150 million, starting August 10, 2026, and continuing until the total purchase reaches €150 million or by December 2026. The buyback is authorized by the company's management an...
